Efficacy and Safety of Nebulized Sodium Bicarbonate in Adults with COVID-19 (SODIC): A Randomized, Single-Center, Double-Blinded, Controlled Trial
Nebulized sodium bicarbonate (8.4%) could be a possible adjuvant therapy for patients with moderate and severe COVID‑19. ClinicalTrials.gov identifier: NCT05035524.
Authors
- Tamer Elhadidy (ORCID: https://orcid.org/0000-0003-0733-7426)
- Rehab Ahmad Elmorsey (ORCID: https://orcid.org/0000-0002-7134-5861)
- Adel El‐Badrawy
- Mohammed Shehta
- Ibrahim El-Said Abdelwahab
- Ahmed A. Shokeir (ORCID: https://orcid.org/0000-0001-6386-3215)
- M Elbadrawy
- Mahmoud M. Elhosiny (ORCID: https://orcid.org/0000-0002-2396-6807)
Institutions
- Mansoura University (EG)
Publication Details
- Journal
- Current Therapeutic Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.curtheres.2025.100801
- Primary Topic
- Cardiac Arrest and Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00